Earnings Per Share, Basic in USD/shares of Nabriva Therapeutics plc from 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Nabriva Therapeutics plc quarterly/annual Earnings Per Share, Basic history and change rate from 2014 to Q2 2023.
  • Nabriva Therapeutics plc Earnings Per Share, Basic for the quarter ending 30 Jun 2023 was -3.73 USD/shares, a 14.8% increase year-over-year.
  • Nabriva Therapeutics plc Earnings Per Share, Basic for the twelve months ending 30 Jun 2023 was -18 USD/shares, a 50.5% increase year-over-year.
  • Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2022 was -21.3 USD/shares, a 25.2% increase from 2021.
  • Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2021 was -28.5 USD/shares, a 78.9% increase from 2020.
  • Nabriva Therapeutics plc annual Earnings Per Share, Basic for 2020 was -135 USD/shares, a 1113% decline from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$18 -$4 +$0.65 +14.8% 01 Apr 2023 30 Jun 2023 10-Q 19 Oct 2023
Q1 2023 -$19 -$3 +$2.31 +45.9% 01 Jan 2023 31 Mar 2023 10-Q 22 May 2023
Q4 2022 -$21 -$8 +$14.70 +65.7% 01 Oct 2022 31 Dec 2022 10-K 17 Apr 2023
Q3 2022 -$36 -$4 +$1.06 +20.1% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 -$37 -$4 -$4 -1410% 01 Apr 2022 30 Jun 2022 10-Q 19 Oct 2023
Q1 2022 -$33 -$5 -$5 -849% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q4 2021 -$29 -$22 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 -$5 -$4 -486% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $0 +$1.08 +78.8% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$1 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q3 2020 -$1 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$1 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q2 2017 -$20 -$1 +$0.03 +5.26% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 -$20 -$6 +$0.82 +12.8% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2017
Q4 2016 -$20 -$7 -$3 -80.5% 01 Oct 2016 31 Dec 2016 10-K 24 Mar 2017
Q3 2016 -$17 -$7 +$0.88 +11.8% 01 Jul 2016 30 Sep 2016 10-K 24 Mar 2017
Q2 2016 -$18 -$1 +$37.00 +98.5% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 -$55 -$6 +$24.20 +79% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 -$79 -$4 01 Oct 2015 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 -$7 01 Jul 2015 30 Sep 2015 10-K 24 Mar 2017
Q2 2015 -$38 01 Apr 2015 30 Jun 2015 10-K 24 Mar 2017
Q1 2015 -$31 01 Jan 2015 31 Mar 2015 10-K 24 Mar 2017

Nabriva Therapeutics plc Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$21 +$7.20 +25.2% 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023
2021 -$29 +$107 +78.9% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 -$135 -$124 -1113% 01 Jan 2020 31 Dec 2020 10-K 17 Apr 2023
2019 -$11 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022
2016 -$26 +$22.50 +46.8% 01 Jan 2016 31 Dec 2016 10-K 24 Mar 2017
2015 -$48 -$4 -8.2% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017
2014 -$44 01 Jan 2014 31 Dec 2014 10-K 24 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.